Structural mapping of PEAK pseudokinase interactions identifies 14-3-3 as a molecular switch for PEAK3 signaling

被引:0
|
作者
Michael J. Roy
Minglyanna G. Surudoi
Ashleigh Kropp
Jianmei Hou
Weiwen Dai
Joshua M. Hardy
Lung-Yu Liang
Thomas R. Cotton
Bernhard C. Lechtenberg
Toby A. Dite
Xiuquan Ma
Roger J. Daly
Onisha Patel
Isabelle S. Lucet
机构
[1] The Walter and Eliza Hall Institute of Medical Research,Department of Medical Biology
[2] University of Melbourne,Cancer Program, Biomedicine Discovery Institute
[3] Monash University,Department of Biochemistry and Molecular Biology
[4] Monash University,undefined
来源
关键词
D O I
暂无
中图分类号
学科分类号
摘要
PEAK pseudokinases regulate cell migration, invasion and proliferation by recruiting key signaling proteins to the cytoskeleton. Despite lacking catalytic activity, alteration in their expression level is associated with several aggressive cancers. Here, we elucidate the molecular details of key PEAK signaling interactions with the adapter proteins CrkII and Grb2 and the scaffold protein 14-3-3. Our findings rationalize why the dimerization of PEAK proteins has a crucial function in signal transduction and provide biophysical and structural data to unravel binding specificity within the PEAK interactome. We identify a conserved high affinity 14-3-3 motif on PEAK3 and demonstrate its role as a molecular switch to regulate CrkII binding and signaling via Grb2. Together, our studies provide a detailed structural snapshot of PEAK interaction networks and further elucidate how PEAK proteins, especially PEAK3, act as dynamic scaffolds that exploit adapter proteins to control signal transduction in cell growth/motility and cancer.
引用
收藏
相关论文
共 50 条
  • [31] 14-3-3 molecular mechanism and biochemical properties
    Schmauder, R
    van Heemert, M
    Spaink, HP
    Schmidt, T
    BIOPHYSICAL JOURNAL, 2002, 82 (01) : 331A - 331A
  • [32] CDPKs and 14-3-3 Proteins: Emerging Duo in Signaling
    Ormancey, Melanie
    Thuleau, Patrice
    Mazars, Christian
    Cotelle, Valerie
    TRENDS IN PLANT SCIENCE, 2017, 22 (03) : 263 - 272
  • [33] Regulatory role of 14-3-3η on the glucocorticoid signaling pathway
    Na, DS
    Kim, YS
    Lee, HJ
    Ko, JS
    FASEB JOURNAL, 2004, 18 (08): : C255 - C255
  • [34] Role of 14-3-3 proteins in eukaryotic signaling and development
    Darling, DL
    Yingling, J
    Wynshaw-Boris, A
    CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY, VOLUME 68, 2005, 68 : 281 - +
  • [35] 14-3-3 Proteins in Plant-Pathogen Interactions
    Lozano-Duran, Rosa
    Robatzek, Silke
    MOLECULAR PLANT-MICROBE INTERACTIONS, 2015, 28 (05) : 511 - 518
  • [36] Specificity of 14-3-3 isoform dimer interactions and phosphorylation
    Aitken, A
    Baxter, H
    Dubois, T
    Clokie, S
    Mackie, S
    Mitchell, K
    Peden, A
    Zemlickova, E
    BIOCHEMICAL SOCIETY TRANSACTIONS, 2002, 30 : 351 - 360
  • [37] Mutational analysis of the 14-3-3/ligand interactions.
    Wang, HN
    Zhang, LX
    Fu, H
    MOLECULAR BIOLOGY OF THE CELL, 1996, 7 : 55 - 55
  • [38] Targeting 14-3-3/ligand interactions in NSCLC.
    Park, HR
    Luhn, PA
    Zhang, HY
    Montoya, LM
    Sun, SY
    Khuri, FR
    Fu, H
    CLINICAL CANCER RESEARCH, 2003, 9 (16) : 6242S - 6242S
  • [39] Modulators of 14-3-3 Protein-Protein Interactions
    Stevers, Loes M.
    Sijbesma, Eline
    Botta, Maurizio
    MacKintosh, Carol
    Obsil, Tomas
    Landrieu, Isabelle
    Cau, Ylenia
    Wilson, Andrew J.
    Karawajczyk, Anna
    Eickhoff, Jan
    Davis, Jeremy
    Hann, Michael
    O'Mahony, Gavin
    Doveston, Richard G.
    Brunsveld, Luc
    Ottmann, Christian
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (09) : 3755 - 3778
  • [40] Study of the interactions between 14-3-3 protein and phosducin
    Rezabkova, L.
    Kacirova, M.
    Herman, P.
    Vecer, J.
    Sulc, M.
    Obsil, T.
    FEBS JOURNAL, 2010, 277 : 181 - 181